Besides, As-IV improved pulmonary function via suppressing the secretion of IL-6 and tumor necrosis factor-alpha (TNF-α) in the chronic hypoxia-induced pulmonary hypertension model [20]. This evidence concerns the gene TNF and pulmonary arterial hypertension.